Please use this identifier to cite or link to this item: http://hdl.handle.net/11455/70587
標題: Rutin inhibits the proliferation of murine leukemia WEHI-3 cells in vivo and promotes immune response in vivo
作者: Lin, J.P.
Yang, J.S.
Lu, C.C.
Chiang, J.H.
Wu, C.L.
Lin, J.J.
Lin, H.L.
Yang, M.D.
Liu, K.C.
Chiu, T.H.
Chung, J.G.
關鍵字: Rutin;WEHI-3 leukemia cells;BALB/c mice;Immune response;Cytotoxicity;aberrant crypt foci;balb/c mice;quercetin;azoxymethane;vitamin-d-3;cancer;vitro
Project: Leukemia Research
期刊/報告no:: Leukemia Research, Volume 33, Issue 6, Page(s) 823-828.
摘要: 
Flavonoids are polyphenolic compounds found in various foods of plants. Rutin, one of the flavonoids. had been showed induced apoptosis in cancer cells. There is no available information to address rutin affects murine leukemia cells in vivo. In the present study, We are focused on the in vivo effects of rutin on leukemia WEHI-3 cells. The effects of rutin on WEHI-3 in BALB/c mice in vivo were also examined and the results indicated that rutin decreased the percentage of Mac-3 marker, indicating that the differentiation of the precursor of macrophage and T cells was inhibited. The weights of liver and spleen were decreased from rutin-treated groups compared to the control groups and the results indicated that rutin decreased the weight of these organs. One of the major characteristic of WEHI-3 leukemia is the enlarged spleen in murine after i.p. injection of WEHI-3 cells. After the pathological examination, the function of rutin in was observed in the liver and spleen in the mice previously injected with WEHI-3 cells. Rutin Promoted the activity of macrophage phagocytosis in cells which isolated from peritoneal (i.p.). Taken together, rutin can affect WEHI-3 cells in vivo. (C) 2008 Elsevier Ltd. All rights reserved.
URI: http://hdl.handle.net/11455/70587
ISSN: 0145-2126
DOI: 10.1016/j.leukres.2008.09.032
Appears in Collections:期刊論文

Show full item record
 

Google ScholarTM

Check

Altmetric

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.